Ernexa Therapeutics Inc. (ERNA) Corporate Subsidiaries
Ernexa Therapeutics Inc. (ERNA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ERNA
CIK: 748592
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerWayne Pinnell
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001493152-26-047287 | View SEC Doc Filr Page |
| 3 | 2026-09-22 | 2026-09-14 | 3 | 0001493152-26-043714 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001493152-26-042963 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-14 | 8-K | 0001493152-26-042934 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 | 0001493152-26-041137 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 | 0001493152-26-041135 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 | 0001493152-26-041133 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 | 0001493152-26-041132 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 | 0001493152-26-041131 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 | 0001493152-26-041130 | View SEC Doc Filr Page |
| 3 | 2026-08-27 | 2026-08-04 | 3 | 0001493152-26-040466 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001493152-26-036424 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | 8-K | 0001493152-26-031930 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-01 | 8-K | 0001493152-26-031920 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-22 | 8-K | 0001493152-26-030306 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-20 | — | SCHEDULE 13G/A Filing | 0001708828-26-000225 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-227556 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-227548 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0001171520-26-000096 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0001708828-26-000185 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001104659-26-060524 | View SEC Doc Filr Page |
| ARS | 2026-05-11 | 2025-12-31 | ARS | 0001493152-26-022288 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-11 | — | DEFA14A | 0001493152-26-022284 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-11 | 2026-05-11 | DEF 14A | 0001493152-26-022281 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001493152-26-022276 | View SEC Doc Filr Page |